Test Code LABICRESP Immunocompromised Respiratory Panel
Clinical Information
Detection from respiratory specimens: Adenovirus, Coronavirus (serotypes HKU1, NL63, 229E, OC43), SARS-CoV-2, Human metapneumovirus, Human rhinovirus/enterovirus, Influenza A (H1, H1-2009, H3), Influenza B, Parainfluenza virus (serotypes 1-4), Respiratory syncytial virus (RSV), Bordetella pertussis, Bordetella parapertussis, Chlamydia pneumoniae, Mycoplasma pneumoniae.
Synonym
- ICRESP
- BioFire RP2.1
Profile Information
Reporting Name | Available Separately | Always Reported |
---|---|---|
Influenza A | No | Yes |
Influenza B | No | Yes |
RSV | No | Yes |
Parainfluenza 1 | No | Yes |
Parainfluenza 2 | No | Yes |
Parainfluenza 3 | No | Yes |
Parainfluenza 4 | No | Yes |
Metapneumovirus | No | Yes |
Rhinovirus/Enterovirus | No | Yes |
Adenovirus | No | Yes |
Coronavirus 229E | No | Yes |
Coronavirus NL63 | No | Yes |
Coronavirus HKU1 | No | Yes |
Coronavirus OC43 | No | Yes |
Bordetella paraertussis | No | Yes |
Bordetella pertussis | No | Yes |
Chlamydia pneumoniae | No | Yes |
Mycoplasma pneumoniae | No | Yes |
Influenza A Subtype H1 | No | Yes |
Influenza A Subtype H3 | No | Yes |
Influenza A Subtype 2009 H1N1 | No | Yes |
SARS-COV-2 | No | Yes |
Specimen Required
Preferred Container/Tube: Viral Transport Media (VTM)
Acceptable Container/Tube: Viral Transport Media (VTM)
Specimen Source: Nasopharyngeal
Preferred Container/Tube: Sterile Container
Acceptable Container/Tube: Sterile Container
Specimen Source: BAL
Specimen Minimum Volume: 1 mL
Preferred Container/Tube: Sterile Container
Acceptable Container/Tube: Sterile Container
Specimen Source: CSF
Specimen Minimum Volume: 0.5 mL
Specimen Stability Information
Ambient: 4 hours
Refrigerated: 3 days
Reference Values
Not Detected (for all targets)
Interpretation
Nasopharyngeal Source
Results should be used in conjunction with other clinical and laboratory findings. This result does not rule out co-infections with pathogens that are not screened for by the Respiratory Panel(RP). This RP assay was performed using a Film Array multiplex nucleic acid assay.
BAL Source
Results should not be used in conjunction with other clinical and laboratory findings. This result does not rule out co-infections with pathogens that are not screened for by the Respiratory Panel(RP). This RP assay was performed using a Film Array multiplex nucleic acid assay. This test was developed and its performance characteristics determined by The Clinical Microbiology Laboratory at The Ohio State University Wexner Medical Center. It has not been cleared or approved by the FDA. The laboratory is required under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research.
Cautions
This test is not a test of cure.
Method Description
Multiplex polymerase chain reaction (PCR)
Performing Lab
Clinical Lab University East
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 day
Reporting Name
Immunocompromised Respiratory Panel
CPT Code Information
NP
0202U
BAL
87633
87798 x2
87486
87581
LOINC Code Information
34487-9
49521-8
49524-2
55465-9
40982-1
29908-1
29909-9
29910-7
41010-0
67820-1
40991-2
82163-7
82162-9
82161-1
82164-5
40988-8
40976-3
29723-4
23826-1
34645-2
29257-3
94309-2